Drugs Made In America Acquisition (DMIIR) Assets Average (2025 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Assets Average of $503.0 million for Q4 2025, up 100.73% quarter-over-quarter from $250.6 million in Q3 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Assets Average (2025 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Assets Average for 1 consecutive years, with $503.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average changed N/A year-over-year to $503.0 million; the TTM figure through Dec 2025 stood at $503.0 million (changed N/A YoY), while the FY2025 annual figure was $252.5 million, changed N/A from the prior year.
- Assets Average rose to $503.0 million in Q4 2025 per DMIIR's latest filing, from $250.6 million in the prior quarter.
- Across five years, Assets Average topped out at $503.0 million in Q4 2025 and bottomed at $250.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 371.49 Mn |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | 303.01 Mn |
| 4 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | 240.32 Mn |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | 262.37 Mn |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | 260.40 Mn |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | 288.73 Mn |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | 237.18 Mn |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | 247.95 Mn |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | 509.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 509.53 Mn |
| Dec 31, 2025 | 502.98 Mn |
| Sep 30, 2025 | 250.57 Mn |